Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Daniel Quirk is active.

Publication


Featured researches published by Daniel Quirk.


Gastroenterology | 1997

Physician Specialty and Variations in the Cost of Treating Patients With Acute Upper Gastrointestinal Bleeding

Daniel Quirk; Michael J. Barry; Bernard Aserkoff; Daniel K. Podolsky


Gastroenterology | 1997

Physician specialty and cost-effectiveness of diverticulitis care: A difficult knot to untangle

Daniel Quirk; Michael J. Barry


Gastroenterology | 2018

Sa1753 - Tofacitinib Achieves Symptomatic Improvement within 3 Days in Moderately to Severely Active Ulcerative Colitis, Regardless of Prior Tumour Necrosis Factor Inhibitor Treatment Status: Results from Octave Induction 1 & 2

Stephen B. Hanauer; Remo Panaccione; Silvio Danese; Adam S. Cheifetz; Walter Reinisch; Peter D. Higgins; Deborah A Woodworth; Haiying Zhang; Gary S. Friedman; Nervin Lawendy; Daniel Quirk; Chudy I. Nduaka; Chinyu Su


Gastroenterology | 2018

Sa1742 - Efficacy and Safety of an Additional 8 Weeks of Tofacitinib Induction Therapy: Results of the Octave Open Study for Tofacitinib 8-Week Induction Non-Responders

Brian G. Feagan; Marla Dubinsky; Milan Lukas; Daniel Quirk; Chudy I. Nduaka; Eric S. Maller; Nervin Lawendy; Cem Kayhan; Wenjin Wang; Gary Chan; Chinyu Su


Gastroenterology | 2018

Sa1763 - Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Malignancy Rates from the Octave Clinical Program

Gary R. Lichtenstein; Matthew A. Ciorba; Gerhard Rogler; Daniel Quirk; Chudy I. Nduaka; R. Pedersen; Nervin Lawendy; Gary Chan; Chinyu Su; Julián Panés


Gastroenterology | 2018

Mo1163 - Gastrointestinal Bleeding in Patients on Novel Oral Anticoagulants Compared to Warfarin: Localization and Prevention

Divya M. Chalikonda; Charles A. Kistler; Daniel Quirk; Stephanie M. Moleski


Gastroenterology | 2018

Sa1750 - The Effect of Tofacitinib on Serum Lipids and Cardiovascular Safety in Patients with Ulcerative Colitis - Results from the Tofacitinib Ulcerative Colitis Clinical Program

Bruce E. Sands; Pam R. Taub; Brian G. Feagan; Alessandro Armuzzi; Gary S. Friedman; Michele Moscariello; Nervin Lawendy; R. Pedersen; Gary Chan; Chudy I. Nduaka; Daniel Quirk; Leonardo Salese; Chinyu Su


Gastroenterology | 2018

Sa1765 - Correlation of Lipid Levels with Reduction in Inflammation in Patients with Ulcerative Colitis: Data from the Tofacitinib Octave Clinical Trials

Brian G. Feagan; Christina Y. Ha; Pam R. Taub; Daniel Quirk; Chudy I. Nduaka; Leonardo Salese; Gary Chan; Gary S. Friedman; Wenjin Wang; Chinyu Su; Walter Reinisch


Gastroenterology | 2017

Ten Years of Radiofrequency Ablation (RFA) for Barrett's Esophagus: A Single Center Experience

Christina Tofani; Kunjal Gandhi; Joseph Spataro; Joseph Yoo; Neena Mohan; Megan Murphy; Raymond Janowski; Zachary Daitch; Nooreen Dabbish; Scott W. Keith; Robert M. Coben; David Kastenberg; Daniel Quirk; Ali Siddiqui; Sidney Cohen; Anthony Infantolino


Gastroenterology | 2012

Su1140 Boerhaave's Syndrome as a First Presentation of Eosinophilic Esophagitis

Whitney E. Jackson; Vaibhav Mehendiratta; Juan P. Palazzo; Anthony J. DiMarino; Daniel Quirk; Sidney Cohen

Collaboration


Dive into the Daniel Quirk's collaboration.

Top Co-Authors

Avatar

Chinyu Su

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daniel K. Podolsky

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Brian G. Feagan

University of Western Ontario

View shared research outputs
Top Co-Authors

Avatar

Sidney Cohen

United States Department of Veterans Affairs

View shared research outputs
Researchain Logo
Decentralizing Knowledge